Which statement best describes the mechanism of fumonisin toxicity with respect to sphingolipid metabolism?

Get ready for the ACVPM Toxicology Exam with our comprehensive quiz. Enhance your knowledge with multiple-choice questions and detailed explanations. Prepare effectively for your certification exam!

Multiple Choice

Which statement best describes the mechanism of fumonisin toxicity with respect to sphingolipid metabolism?

Explanation:
Fumonisins disrupt sphingolipid metabolism by inhibiting ceramide synthase, the enzyme that converts sphinganine into ceramide. This blocks the progression of sphingolipid biosynthesis, causing buildup of sphinganine and a shortage of ceramide and downstream sphingolipids. The resulting imbalance in sphingolipid homeostasis affects membrane structure and signaling in liver cells, leading to hepatic dysfunction. The statement that describes inhibition of the step from sphinganine toward downstream sphingolipids (toward sphingosine/ceramide) best captures this mechanism, since the key effect is blocking the conversion of sphinganine to downstream sphingolipid products.

Fumonisins disrupt sphingolipid metabolism by inhibiting ceramide synthase, the enzyme that converts sphinganine into ceramide. This blocks the progression of sphingolipid biosynthesis, causing buildup of sphinganine and a shortage of ceramide and downstream sphingolipids. The resulting imbalance in sphingolipid homeostasis affects membrane structure and signaling in liver cells, leading to hepatic dysfunction. The statement that describes inhibition of the step from sphinganine toward downstream sphingolipids (toward sphingosine/ceramide) best captures this mechanism, since the key effect is blocking the conversion of sphinganine to downstream sphingolipid products.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy